Skip to content

Clinical trials

Recruiting Anemia, Refractory, with Excess of Blasts trials with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Anemia, Refractory, with Excess of Blasts Phase: Not applicable Status: Recruiting Clear all

6 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20201
20211
20231
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting6

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Institute of Oncology1
Fujian Medical University Union Hospital1
Institute of Hematology & Blood Diseases Hospital, China1
Medical College of Wisconsin1
The First Affiliated Hospital of Soochow University1
University Hospital, Bordeaux1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Anemia, Refractory, with Excess of Blasts6
Leukemia, Myeloid, Acute4
Burkitt Lymphoma1
Carcinoma, Ovarian Epithelial1
Leukemia1
Leukemia, Biphenotypic, Acute1
Leukemia, Myeloid, Accelerated Phase1
Leukemia, Myeloid, Chronic-Phase1
Myelodysplastic Syndromes1
Precursor Cell Lymphoblastic Leukemia-Lymphoma1

Trials

Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.